← Back to Patent Explorer
EP0107095A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

1-N-alkylcarboxy-benzofused lactams useful as antihypertensive agents

Assignee: Merck and Co Inc
•
Filing: 1983-09-28
•
Granted: —
•
Expires: 2003-09-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the formula: wherein: R' is, e.g., hydrogen or alkyl of from 1 to 12 carbon atoms; R 2 and R 4 are independently, e.g., hydroxy or loweralkoxy; m is 1-4; R' is n is 2-5; provided that where n = 3 or 4, the carbon chain may be unsaturated between carbons 2-3 for n = 3, and between carbons 2-3 or 3-4 or both for n = 4; the R a' S are independently, e.g., hydrogen or hydroxy; and the R b 's are independently hydrogen or loweralkyl; R 5 is hydrogen; halo; hydroxy; loweralkyl; loweralkoxy; amino; or mono- or diloweralkylamino; and a pharmaceutically acceptable salt thereof. Those compounds are inhibotors of angiotensin I converting enzyme useful as antihypertensive agents.

Inventors

  • 👤 William H. Parsons

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-11-05 23:22
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/38; A; A61; A61P; A61P9/00; A61P9/12; C07D223/00; C07D223/14; C07D223/16; C07D225/00; C07D225/04; C07D227/00; C07D227/02; C07D227/06; C07D227/10; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A61K; A61K38/00

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 321 words
A compound of the formula: wherein: R is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched, cyclic and unsaturated alkyl groups; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, or acylamino substituted loweralkyl having the formula R 1 (CH 2 ) n -Q-(CH 2 ) m wherein n is A 0 -2, m is 1-3, R 1 is aryl or heteroaryl A optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, N- , , CO, CH=CH wherein is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R 1 is hydrogen, or loweralkyl; C aryl; substituted aryl wherein the substituent is loweralkyl, aminoloweralkyl, loweralkoxy, aryloxy, aroyl, hydroxy, halo, or dihalo; aralkyl or heteroaralkyl which include branched loweralkyi groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; R 2 and R 4 are independently hydroxy; loweralkoxy; loweralkenyloxy; arloweralkoxy; acylloweralkoxy; amino; loweralkylamino; diloweralkylamino; carboxymethylamino; carboxamidomethylamino; or aryloxy, or mono-or disubstituted aryloxy wherein the substituents are chloro; m is 1-4; R 3 is where n is 2-5; provided that where n=3 or 4, the carbon chain may be unsaturated between carbons 2-3 for n=3, and between carbons 2-3 or 3-4 or both for n=4; the R a 's are independently hydrogen; hydroxy; amino; mono- or diloweralkylamino; loweralkyl; phenyl; phenoxy; phenylloweralkyl; hydroxyphenylloweralkyl; aminoloweralkyl; hydroxyloweralkyl; mercaptoloweralkyl; loweralkylthioloweralkyl; imidazolylloweralkyl; indolylloweralkyl; carboxyl; carboxamide; loweralkoxycarbonyl; carboxyloweralkyl; carboxamidoloweralkyl; or loweralkoxycarbonylloweralkyl; and the R b 's are independently hydrogen or loweralkyl; R 5 is hydrogen; halo: hydroxy; loweralkyl; loweralkoxy; amino; or mono- or diloweralkylamino; and a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 321 words
A compound of the formula: wherein: R is hydrogen; alkyl of from 1 to 12 carbon atoms which include branched, cyclic and unsaturated alkyl groups; substituted loweralkyl wherein the substituent can be halo, hydroxy, carboxy, loweralkylthio, loweralkoxy, loweralkoxycarbonyl, loweraralkoxycarbonyl, amino, loweralkylamino, lowerdialkylamino, or acylamino substituted loweralkyl having the formula R 1 (CH 2 ) n -Q-(CH 2 ) m wherein n is A 0 -2, m is 1-3, R 1 is aryl or heteroaryl A optionally substituted by amino, lowerdialkylamino, loweralkylamino, hydroxy, hydroxyloweralkyl, aminoloweralkyl, trihaloloweralkyl, cyano, nitro, sulfonamido, aroyl, loweralkyl, halo, dihalo, and loweralkoxy, and Q is O, S, N- , , CO, CH=CH wherein is hydrogen, loweralkyl, aryl, aralkyl, loweralkanoyl, or aroyl, and R 1 is hydrogen, or loweralkyl; C aryl; substituted aryl wherein the substituent is loweralkyl, aminoloweralkyl, loweralkoxy, aryloxy, aroyl, hydroxy, halo, or dihalo; aralkyl or heteroaralkyl which include branched loweralkyi groups; substituted aralkyl or substituted heteroaralkyl which include branched loweralkyl groups wherein the loweralkyl groups can be substituted by amino, acylamino, or hydroxyl and the aryl and heteroaryl groups can be substituted by halo, dihalo, loweralkyl, hydroxy, loweralkoxy, aryloxy, aroyl, arylthio, amino, aminoloweralkyl, loweralkanoylamino, aroylamino, lowerdialkylamino, loweralkylamino, hydroxyloweralkyl, trihaloloweralkyl, nitro, cyano, or sulfonamido; R 2 and R 4 are independently hydroxy; loweralkoxy; loweralkenyloxy; arloweralkoxy; acylloweralkoxy; amino; loweralkylamino; diloweralkylamino; carboxymethylamino; carboxamidomethylamino; or aryloxy, or mono-or disubstituted aryloxy wherein the substituents are chloro; m is 1-4; R 3 is where n is 2-5; provided that where n=3 or 4, the carbon chain may be unsaturated between carbons 2-3 for n=3, and between carbons 2-3 or 3-4 or both for n=4; the R a 's are independently hydrogen; hydroxy; amino; mono- or diloweralkylamino; loweralkyl; phenyl; phenoxy; phenylloweralkyl; hydroxyphenylloweralkyl; aminoloweralkyl; hydroxyloweralkyl; mercaptoloweralkyl; loweralkylthioloweralkyl; imidazolylloweralkyl; indolylloweralkyl; carboxyl; carboxamide; loweralkoxycarbonyl; carboxyloweralkyl; carboxamidoloweralkyl; or loweralkoxycarbonylloweralkyl; and the R b 's are independently hydrogen or loweralkyl; R 5 is hydrogen; halo: hydroxy; loweralkyl; loweralkoxy; amino; or mono- or diloweralkylamino; and a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 59 words
A compouna according to Claim 1 selected from the group consisting essentially of: 1-ethoxycarbonylethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminohomodihydrocarbostyril; 1-carboxyethyl-3-(1-carboxy-3-phenyl-1-propyl)aminohomodihydrocarbostyril; 1-ethoxycarbonylethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminohexahydrobenzoazocine-2-one; 1-carboxyethyl-3-(1-carboxy-3-phenyl-1-propyl) aminohexahydrobenzoazocine-2-one, and ethyl diester; 1-(3-carboxypropyl)-3-(l-carboxy-3-phenyl-l-propyl) aminohomodihydrocarbostyril, and ethyl diester; 1-(4-carboxybutyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohomodihydrocarbostyril, and ethyl diester; 1-carboxyethyl-3-(1-carboxy-3-phenyl-1-propyl) aminodihydrocarbostyril, and ethyl diester; 1-(3-carboxypropyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohexahydrobenzoazocine-2-one, and ethyl diester; 1-(4-carboxybutyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohexahydrobenzoazocine-2-one, and ethyl diester; 1-(3-carboxypropyl)-3-(1-carboxy-3-phenyl 1-propyl) aminodihydrocarbostyril, and ethyl diester; 1-(4-carboxybutyl)-3-(l-carboxy-3-phenyl-l-propyl) aminodihydrpcarbostyril, and ethyl diester; 1-ethoxycarbonylethyl-3-(1-carboxy-3-phenyl-1-propyl) aminohomodihydrocarbostyril.
Claim 4
Dependent Claim 23 words
A pharmaceutical composition useful in treating hypertension comprising a pharmaceutically acceptable carrier and an antihypertensively effective amount of a compound of Claim 1:
Claim 5
Dependent Claim 64 words
A composition according to Claim 3 wherein said compound is a member selected from the group consisting essentially of: 1-ethoxycarbonylethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminohomodihydrocarbostyril; 1-carboxyethyl-3-(1-carboxy-3-phenyl-1-propyl)aminohomodihydrocarbostyril; 1-ethoxycarbonylethyl-3-(1-carboethoxy-3-phenyl-1-propyl)aminohexahydrobenzoazocine-2-one; 1-carboxyethyl-3-(1-carboxy-3-phenyl-1-propyl) aminohexahydrobenzoazocine-2-one, and ethyl diester; 1-(3-carboxypropyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohomodihydrocarbostyril, and ethyl diester; 1-(4-carboxybutyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohomodihydrocarbostyril, and ethyl diester; l-carboxyethyl-3-(l-carboxy-3-phenyl-l-propyl) aminodihydrocarbostyril, and ethyl diester; 1-(3-carboxypropyl)-3-(1-carboxy-3-phenyl-1-propyl) aminohexahydrobenzoazocine-2-one, ana ethyl diester; 1-(4-carboxybutyl)-3-(1-carboxy-3-phenyl-l-propyl) aminohexahydrobenzoazocine-2-one, and ethyl diester; 1-(3-carboxypropyl)-3-(1-carboxy-3-phenyl-1-propyl) aminodihydrocarbostyril, and ethyl diester; 1-(4-carboxybutyl)-3-(1-carboxy-3-phenyl-1-propyl) aminodihydrocarbostyril, and ethyl diester; l-ethoxycarbonylethyl-3-(l-carboxy-3-phenyl-l-propyl) aminohomodihydrocarbostyril.
Claim 6
Dependent Claim 101 words
A composition according to Claim 3 which includes an antihypertensively effective amount of an antihypertensive and/or diuretic compound selected from the group consisting of acetazolamide, amiloride, aminophylline, atenolol, bendroflumethiazide, benzthiazide, bumetanide, chlorothalidone, chlorothiazide, clonidine, cryptenamine acetates and cryptenamine tannates, cyclothiazide, deserpidine, diazoxide, diltiazem, (S)-1-[[2-(3,4-dimethoxyphenyl)-ethyl]amino]-3-[[4-(2-thienyl)-lH-imidazol-2-yl]-phenox y]-2-propanol, ethacrynic acid, flumethiazide, furosemide, guanethidene sulfate, hydralazine hydrochloride, hydrochlorothiazaide, hydro- flumethiazide, (+)-4-[3-[-[2-(1-hydroxycyclohexyl)ethyl]4-oxo-2-thiazolidinyl]propyl]-benzoic acid, indacrinone and variable ratios of its enantiomers, merethoxylline procaine, methylclothiazide, methyldopa, methyldopate hydrochloride, metolazone, metoprolol tartate, minoxidil, naldolol, nifedipine, pargyline hydrochloride, pindolol, polythiazide, prazosin, propranolol, quinethazone, rauwolfia serpentina, rescinnamine, reserpine, sodium ethacrynate, sodium nitroprusside, spironolactone, ticrynafen, timolol, triamterene, trichlormethiazide, trimethophan camsylate, and verapamil.

References Cited (Backward Citations)

EP0046291A2 Cited
EP0046292A1 Cited
EP0046289A2 Cited
EP0072352B1 Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag